Rules and Regulations. Notice of Intent

Agency: Office of Research and Development, Department of Veterans Affairs
Action: Notice of Intent
Citation: FR Doc. 2014-00048

Summary

Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development (ORD), intends to grant to Primorigen Biosciences, Inc., 510 Charmany Drive, Madison, WI 53719, USA, an exclusive license to practice the following: U.S. Patent Application Serial No. 13/225,441 and PCT Application Number PCT/US11/50462, “Efficient Generation of Neurally-Induced Mesenchymal Stem Cells and Applications Thereof,” filed September 3, 2011, and any subsequent non-provisional patent application(s) that will claim the benefit of U.S. Patent Application Serial No. 13/225,441 and PCT Application Number PCT/US11/50462, “Efficient Generation of Neurally-Induced Mesenchymal Stem Cells and Applications Thereof.”

Dates

Comments must be received within 15 days from the date of this published Notice.

Supplementary Information

It is in the public interest to license this invention, as Primorigen Biosciences, Inc. submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted, unless VA ORD receives written evidence and argument within 15 days from the date of this published Notice, which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Dated: December 31, 2013. Jose D. Riojas, Chief of Staff, Department of Veterans Affairs. [FR Doc. 2014-00048 Filed 1-6-14; 8:45 am]